Fibroid embolisation (uterine artery embolisation, which blocks the vessels that supply the fibroid) and myomectomy (surgical removal of the fibroid) are the two main conservative treatments for symptomatic fibroids when a woman wishes to keep her uterus. In the British randomised FEMME trial (254 women, New England Journal of Medicine, 2020), fibroid-related quality of life at 2 years was better after myomectomy (score of 84.6 versus 80.0 out of 100). Embolisation, on the other hand, offers faster recovery and fewer transfusions, at the cost of a higher risk of further intervention: according to Cochrane, if 7% of women who have surgery need another procedure within 2 years, this rate is estimated at 15 to 32% after embolisation.
Myomectomy is a surgical operation that removes the fibroid or fibroids while preserving the uterus. It is performed by hysteroscopy (fibroids within the cavity), laparoscopy or laparotomy depending on the position and size of the fibroids. It is carried out by a gynaecological surgeon, most often under general anaesthesia.
Uterine artery embolisation is performed by an interventional radiologist. Under local anaesthesia and sedation, a fine catheter is inserted into the femoral artery (in the groin) or the radial artery (at the wrist) and guided to the uterine arteries. Tiny particles are injected there to block the blood supply to the fibroids, which then necrose and gradually shrink. There is no incision and no scar on the uterus.
The FEMME trial, conducted in 29 British hospitals, is the largest randomised trial directly comparing the two treatments in women with symptomatic fibroids who did not want a hysterectomy.
Its main results at 2 years:
This trial included myomectomies by laparotomy, laparoscopy and hysteroscopy, which reflects real-world practice.
The Cochrane review by Gupta et al. (7 trials, 793 women) compared embolisation with surgery (hysterectomy or myomectomy):
A meta-analysis published in AJOG in 2024 (6 randomised trials comparing embolisation and myomectomy) found a risk of repeat intervention about three times lower after myomectomy, with no difference in serious complications. When the analysis is limited to trials in which the surgery group included only myomectomies, quality of life is better after myomectomy. The authors consider the data on pregnancy after embolisation to be very uncertain.
| Criterion | Myomectomy | Uterine artery embolisation |
|---|---|---|
| Who performs it | Gynaecological surgeon | Interventional radiologist |
| Anaesthesia | General in most cases | Local with sedation |
| Scar | Depending on the approach: none (hysteroscopy), small incisions (laparoscopy), abdominal incision (laparotomy) | Puncture site in the groin or wrist |
| Hospital stay | From day surgery (hysteroscopic route) to 3 to 5 days (laparotomy) | Shorter than for surgery in published trials |
| Pain afterwards | Scar pain, decreasing | Intense pelvic pain in the first 24 to 48 hours, treated with strong painkillers |
| Return to activities | Slower (especially after laparotomy) | Faster |
| Fibroid removed and analysed | Yes, microscopic examination | No, the fibroid stays in place and shrinks |
| Quality of life at 2 years (FEMME) | Better | Slightly lower |
| Further intervention | Less frequent | More frequent (15 to 32% at 2 years according to Cochrane) |
| Transfusion | Possible, especially with multiple fibroids | Rare |
| Pregnancy plans | Preferred option | Limited data; not recommended as first-line |
| Ovarian reserve | Little affected | Possible reduction, especially after 45 |
This is the most decisive criterion. The Cochrane review presents embolisation as a safe, minimally invasive alternative to surgery for women who do not wish to become pregnant.
When a pregnancy is planned, myomectomy generally remains the preferred option:
Pregnancies are possible after embolisation, but data are scarce. In the Cochrane review, an analysis limited to a small subgroup suggested fewer births after embolisation than after myomectomy, with a very low level of evidence; the AJOG meta-analysis also considers these data very uncertain. Embolisation can therefore be discussed case by case, after full information, when surgery is considered too risky.
It is less suitable, or even not advised, in the case of a pedunculated subserosal fibroid (risk of detachment), an intracavitary fibroid that can simply be removed by hysteroscopy, active pelvic infection, or doubt about the benign nature of the tumour, since the fibroid is not analysed.
The choice is based on a precise assessment, most often with a pelvic MRI: number, size, FIGO type and blood supply of the fibroids, and any associated adenomyosis. It takes into account:
The Cochrane review stresses the importance of patient selection and prior information. The decision is shared between the patient, the gynaecologist and the interventional radiologist, who performs the embolisation.
After either treatment, seek medical advice promptly or call 15 (SAMU) or 112 in France, or your local emergency number, in the event of:
Would you like a medical opinion?Appointments in Paris 16th or 5th, or by video consultation.
Book an appointmentNo. The fibroid gradually shrinks over the following months, but stays in place. The aim is to reduce symptoms.
Yes, surgery is possible after failed embolisation. This is one of the reasons why repeat intervention rates are higher after embolisation.
Studies show no clear difference in major complications. Embolisation causes more minor complications, myomectomy more transfusions.
Early menopause is possible, particularly after 45, because the procedure can reduce the blood supply to the ovaries. This risk is part of the information given beforehand.
Uterine artery embolisation is a recognised procedure, covered by the Assurance maladie (French national health insurance) for its approved indications. The precise terms (any extra fees) should be checked with the team performing it. For a myomectomy, you are given a written estimate before the operation.
As a rough guide: after embolisation, usually a day case to under 3 days in hospital, about 1 week off work and a return to sport after around 8 to 10 days; after laparoscopic myomectomy, 2 to 3 days and 2 to 4 weeks off work; after open surgery (laparotomy), 3 to 5 days and 4 to 6 weeks (6 to 8 for a physical job); after hysteroscopic myomectomy, a day case to under 3 days and 2 to 4 days off work. These guidelines are adapted to your situation at your consultation, and the time to wait before a pregnancy is discussed at the post-operative appointment.
A question about your situation?Appointments at the practice or by video consultation, usually within one week to 10 days.
Book an appointmentGeneral information article: it does not replace a medical consultation. In an emergency, call 15 or 112 in France, or your local emergency number.